Activated Androgen Receptor Downregulates E-Cadherin Gene Expression and Promotes Tumor Metastasis

REFERENCES

• Baek, S. H., K. A. Ohgi, C. A. Nelson, D. Welsbie, C. Chen, C. L. Sawyers, D. W. Rose, and M. G. Rosenfeld. 2006. Ligand-specific allosteric regulation of coactivator functions of androgen receptor in prostate cancer cells. Proc. Natl. Acad. Sci. USA 103:3100–3105.
   PubMed Web of Science ®Google Scholar
• Baisch, H., U. Otto, and H. Fack. 1998. Growth of human prostate carcinomas with and without hormone alpha-dehydrotestosterone in nude mice. Euro. Urol. 34:505–511.
   PubMed Web of Science ®Google Scholar
• Batlle, E., E. Sancho, C. Franci, D. Dominguez, M. Monfar, J. Baulida, and A. G. de Herreros. 2000. The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumor cells. Nat. Cell Biol. 2:84–89.
   PubMed Web of Science ®Google Scholar
• Birchmeier, W., and J. Behrens. 2003. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. BBA/Rev. Cancer 1198:11–26.
   Google Scholar
• Bolós, V., H. Peinado, M. A. Perez-Moreno, M. F. Fraga, M. Esteller, and A. Cano. 2003. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressers. J. Cell Sci. 116:499–511.
   PubMed Web of Science ®Google Scholar
• Bolton, E. C., A. Y. So, C. Chaivorapol, C. M. Haqq, H. Li, and K. R. Yamamoto. 2007. Cell- and gene-specific regulation of primary target genes by the androgen receptor. Genes Dev. 21:2005–2017.
   PubMedGoogle Scholar
• Cano, A., M. A. Perez-Moreno, I. Rodrigo, A. Locascio, M. J. Blanco, M. G. DelBarrio, F. Portillo, and M. A. Nieto. 2000. The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2:76–83.
   PubMed Web of Science ®Google Scholar
• Chambers, A. F., A. C. Groom, and L. C. MacDonald. 2002. Dissemination and growth of cancer cells in metastatic sites. Nat. Rev. Cancer 2:563–572.
   PubMed Web of Science ®Google Scholar
• Chesire, D. R., and W. B. Isaacs. 2003. Beta-catenin signaling in prostate cancer: an early perspective. Endocr. Relat. Cancer 10:537–560.
   PubMed Web of Science ®Google Scholar
• Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299.
   PubMedGoogle Scholar
• Christofori, G., and H. Semb. 1999. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem. Sci. 24:73–76.
   PubMed Web of Science ®Google Scholar
• Cunha, G. R., W. Ricke, A. Thomson, P. C. Marker, G. Risbridger, S. W. Hayward, Y. Z. Wang, A. A. Donjacoura, and T. Kurita. 2004. Hormonal, cellular, and molecular regulation of normal andneoplastic prostatic development. J. Steroid Biochem. Mol. Biol. 92:221–236.
   PubMed Web of Science ®Google Scholar
• Dürnberger, H., and K. Kratochwii. 1980. Specificity of tissue interaction and origin of mesenchymal cells in the androgen response of the embryonic mammary gland. Cell 19:465–471.
   PubMedGoogle Scholar
• Fidler, I. J. 2003. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nat. Rev. Cancer 3:453–458.
   PubMed Web of Science ®Google Scholar
• Frixen, U. H., J. Behrens, M. Sachs, G. Eberle, B. Voss, A. Warda, D. Löchner, and W. Birchmeier. 1991. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol. 113:173–185.
   PubMed Web of Science ®Google Scholar
• Fu, M., M. Rao, K. Wu, C. Wang, X. Zhang, M. Hessien, Y. G. Yeung, D. Gioeli, M. J. Weber, and R. G. Pestell. 2004. The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity. J. Biol. Chem. 279:29436–29449.
   PubMed Web of Science ®Google Scholar
• Gaughan, L., I. R. Logan, D. E. Neal, and C. N. Robson. 2005. Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation. Nucleic Acids Res. 33:13–26.
   PubMed Web of Science ®Google Scholar
• Grady, W. M., J. Willis, P. J. Guilford, A. K. Dunbier, T. T. Toro, H. Lynch, G. Wiesner, K. Ferguson, C. Eng, J. G. Park, S. J. Kirn, and S. Markowitz. 2000. Methylation of the CDHI promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat. Genet. 26:16–17.
   PubMed Web of Science ®Google Scholar
• Graff, J. R., J. G. Herman, R. G. Lapidus, H. Chopra, R. Xu, D. F. Jarrard, W. B. Isaacs, P. M. Pitha, N. E. Davidson, and S. B. Baylin. 1995. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res. 55:5195–5199.
   PubMed Web of Science ®Google Scholar
• Gross, M., B. Liu, J. Tan, F. S. French, M. Carey, and K. Shuai. 2001. Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells. Oncogene 20:3880–3887.
   PubMed Web of Science ®Google Scholar
• Gross, M., R. Yang, I. Top, C. Gasper, and K. Shuai. 2004. PIASy-mediated repression of the androgen receptor is independent of sumoylation. Oncogene 23:3059–3066.
   PubMed Web of Science ®Google Scholar
• Guerini, V., D. Sau, E. Scaccianoce, P. Rusmini, P. Ciana, A. Maggi, P. G. V. Martini, B. S. Katzenellenbogen, L. Martini, M. Motta, and A. Poletti. 2005. The androgen derivative 5α-androstane-3β, 17β-diol inhibits prostate cancer cell migration through activation of the estrogen receptor β subtype. Cancer Res. 65:5445–5453.
   PubMed Web of Science ®Google Scholar
• Gupta, G. P., and J. Massague. 2006. Cancer metastasis: building a framework. Cell 127:679–695.
   PubMed Web of Science ®Google Scholar
• Hanahan, D., and R. A. Weinberg. 2000. The hallmarks of cancer. Cell 100:57–70.
   PubMed Web of Science ®Google Scholar
• Handschuh, G., S. Candidus, B. Luber, U. Reich, C. Schott, S. Oswald, H. Becke, P. Hutzler, W. Birchmeier, H. Hofler, and K. F. Becker. 1999. Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility. Oncogene 18:4301–4312.
   PubMed Web of Science ®Google Scholar
• Hara, T., H. Miyazaki, A. Lee, C. P. Tran, and R. E. Reiter. 2008. Androgen receptor and invasion in prostate cancer. Cancer Res. 68:1128–1135.
   PubMed Web of Science ®Google Scholar
• Heuberger, B., I. Fitzka, G. Wasner, and K. Kratochwil. 1982. Induction of androgen receptor formation by epithelium-mesenchymel interaction in embryonic mouse mammary gland. Proc. Natl. Acad. Sci. USA 79:2957–2961.
   PubMed Web of Science ®Google Scholar
• Ishizaka, S., A. Shiroi, S. Kanda, M. Yoshikawa, H. Tsujinoue, S. Kuriyama, T. Hasuma, K. Nakatani, and K. Takahashi. 2002. Development of hepatocytes from embryonic stem cells after transfection with the HNF-3β gene. FASEB J. 16:1444–1446.
   PubMed Web of Science ®Google Scholar
• Kemler, R. 1993. From cadherins to catenins: Cytoplasmatic protein interactions and regulation of cell adhesion. Trends Genet. 9:317–321.
   PubMed Web of Science ®Google Scholar
• Labaree, D. C., T. J. Brown, R. M. Hoyte, and R. B. Hochberg. 1997. 7α-Iodine-125-iodo-5α-dihydrotestosterone: a radiolabeled ligand for the androgen receptor. J. Nuclear Med. 38:402–409.
   PubMedGoogle Scholar
• Lee, H., J. C. Quinn, K. V. Prasanth, V. A. Swiss, K. D. Economides, M. M. Camacho, D. L. Spector, and C. Abate-Shen. 2006. PIAS1 confers DNA-binding specificity on the Msx1 homeoprotein. Genes Dev. 20:784–794.
   PubMedGoogle Scholar
• Lillie, E. O., L. Bernstein, and G. Ursin. 2003. The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer. Breast Cancer Res. 5:164–173.
   PubMedGoogle Scholar
• Liu, Y. N., W. W. Lee, C. Y. Wang, T. H. Chao, Y. V. Chen, and J. H. Chen. 2005. Regulatory mechanisms controlling human E-cadherin gene expression. Oncogene 24:8277–8290.
   PubMed Web of Science ®Google Scholar
• Magee, J. A., L. W. Chang, G. D. Stormo, and J. Milbrandt. 2006. Direct, androgen receptor-mediated regulation of the FKBP5 gene via a distal enhancer element. Endocrinology 147:590–598.
   PubMed Web of Science ®Google Scholar
• Mantovani, A. 2007. Cancer: an infernal triangle. Nature 448:547–548.
   PubMedGoogle Scholar
• Mareel, M., and A. Leroy. 2003. Clinical, cellular, and molecular aspects of cancer invasion. Physiol. Rev. 83:337–376.
   PubMed Web of Science ®Google Scholar
• Moinfar, F., M. Okcu, O. Tsybrovskyy, P. Regitnig, S. F. Lax, W. Weybora, M. Ratschek, F. A. Tavassoli, and H. Denk. 2003. Androgen receptors frequently are expressed in breast carcinomas—potential relevance to new therapeutic strategies. Cancer 98:703–711.
   PubMed Web of Science ®Google Scholar
• Müller, A., B. Homey, H. Soto, N. Ge, D. Catron, M. E. Buchanan, T. McClanahan, E. Murphy, W. Yuan, S. N. Wagner, J. L. Barrera, A. Mohar, E. Verástegui, and A. Zlotnik. 2001. Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50–56.
   PubMed Web of Science ®Google Scholar
• Nagafuchi, A., and M. Takeichi. 1988. Cell binding function of E-cadherin is regulated by the cytoplasmic domain. EMBO J. 7:3679–3684.
   PubMed Web of Science ®Google Scholar
• Nightingale, J., K. S. Chaudhary, P. D. Abely, A. P. Stubbs, H. M. Romanska, S. E. Mitchell, G. W. H. Stamp, and E. N. Lalani. 2003. Ligand activation of the androgen receptor downregulates E-cadherin mediated cell adhesion and promotes apoptosis of prostatic cancer cells. Neoplasia 5:347–361.
   PubMed Web of Science ®Google Scholar
• Peinado, H., E. Ballestar, M. Esteller, and A. Cano. 2004. Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase I (HDACI)/HDAC2 complex. Mol. Cell. Biol. 24:306–319.
   PubMed Web of Science ®Google Scholar
• Peinado, H., F. Portillo, and A. Cano. 2004. Transcriptional regulation of cadherins during development and carcinogenesis. Int. J. Dev. Biol. 48:365–375.
   PubMed Web of Science ®Google Scholar
• Perez-Moreno, M. A., A. Locascio, I. Rodrigo, G. Dhondt, F. Portillo, M. A. Nieto, and A. Cano. 2001. A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions. J. Biol. Chem. 276:27424–27431.
   PubMed Web of Science ®Google Scholar
• Sasisekharan, R., Z. Shriver, G. Venkataraman, and U. Narayanasami. 2002. Roles of heparan-sulphate glycosaminoglycans in cancer. Nat. Rev. Cancer 2:521–528.
   PubMed Web of Science ®Google Scholar
• Shiozaki, H., H. Oka, M. Inoue, S. Tamura, and M. Monden. 1996. E-cadherin mediated adhesion system in cancer cells. Cancer 77:1605–1613.
   PubMed Web of Science ®Google Scholar
• Spady, T. J., D. M. E. Harvell, M. C. Snyder, K. L. Pennington, R. D. McComb, and J. D. Shull. 1998. Estrogen-induced tumorigenesis in the Copenhagen ratdisparate susceptibilities to development of prolactin-producing pituitary tumors and mammary carcinomas. Cancer Lett. 124:95–103.
   PubMedGoogle Scholar
• Sporn, M. B. 1996. The war on cancer. Lancet 347:1377–1381.
   PubMed Web of Science ®Google Scholar
• Strahl, B. D., and C. D. Allis. 2000. The language of covalent histone modifications. Nature 403:41–45.
   PubMed Web of Science ®Google Scholar
• Takeichi, M. 1993. Cadherins in cancer: implications for invasion and metastasis. Curr. Opin. Cell Biol. 5:806–811.
   PubMed Web of Science ®Google Scholar
• Tepass, U., K. Truong, D. Godt, M. Ikura, and M. Peifer. 2000. Cadherins in embryonic and neural morphogenesis. Nat. Rev. Mol. Cell Biol. 1:91–100.
   PubMed Web of Science ®Google Scholar
• Thiery, J. P. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2:442–454.
   PubMed Web of Science ®Google Scholar
• Tóth, K. F., T. A. Knoch, M. Wachsmuth, M. Frank-Stöhr, M. Stöhr, C. P. Bacher, G. Müller, and K. Rippe. 2004. Trichostatin A-induced histone acetylation causes decondensation of interphase chromatin. J. Cell Sci. 117:4277–4287.
   PubMed Web of Science ®Google Scholar
• Visakorpi, T. 2003. The molecular genetics of prostate cancer. Urology 62 (Suppl. 1):3–10.
   PubMedGoogle Scholar
• Yang, J., S. A. Mani, J. L. Donaher, S. Ramaswamy, R. A. Ltzykson, C. Come, P. Savagner, I. Gitelman, A. Richardson, and R. A. Weinberg. 2004. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117:927–939.
   PubMed Web of Science ®Google Scholar
• Zhu, P., S. H. Baek, E. Bourk, K. A. Ohgi, I. Garcia-Bassets, H. Sanjo, S. Akira, P. Kotol, C. Glass, and M. G. Rosenfeld. 2006. Macrophage/cancer cell interactions mediate hormone resistance through a conserved nuclear receptor derepression pathway. Cell 124:615–629.
   PubMed Web of Science ®Google Scholar